First patient is randomized in a late-stage anaesthesiology trial

Phase III multi-center double-blind anaesthesiology study outsourced to GCT by a leading Russian pharmaceutical company gets off the ground within the projected timelines.

Following screening procedures and randomization, first subject successfully underwent a complicated abdominal surgery,  with the use of an inhalational anesthesia this Monday.  Patient feels well now, and GCT team was happy to contribute to his fast recovery.

The study is being conducted at two investigative sites in Russia each aiming to enroll 60 subjects within the aggressive timelines.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.